Man­u­fac­tur­ing roundup: As­traZeneca and Sam­sung ink $350M deal; Michi­gan CD­MO com­pletes ex­pan­sion

Sam­sung’s biotech arm and As­traZeneca are look­ing to work to­geth­er on a con­tract man­u­fac­tur­ing agree­ment.

Ac­cord­ing to a re­port from Ko­rea …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.